COVID-19: Pfizer-BioNTech vaccine 100% effective in 12 to 15-year-olds, say companies
• .Phase 3 trials carried out on 2,260 adolescents in the United States "demonstrated 100 percent efficacy and robust antibody responses", the companies said in a statement
